Pfizer, Merck Acquisitions Put Animal-Drug Products Into Play – Bloomberg
Pfizer, Merck Acquisitions Put Animal-Drug Products Into Play Bloomberg Lilly will lose patent protection in 2011 for its antipsychotic medicine Zyprexa, the company's top product, with $4.7 billion in sales last year. ... |
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments
No comments yet.
Sorry, the comment form is closed at this time.